Researchers in Switzerland are setting their sights on fluoroethyl-tyrosine (FET) PET imaging as the best way to assess adult brainstem glioma and gauge patients’ chances for progression-free survival. Study results were presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. {read more here}